Psychennex Pty Ltd.

Incannex To Prepare FDA IND Application For Psilocybin-Assisted Psychedelic Psychotherapy

Psychennex Pty Ltd, a subsidiary of Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has commenced preparations of an investigational new drug (‘IND’) application to the U.S.

Psychedelic Therapies Soon Available In Australia Via Incannex Healthcare And Subsidiary

Biotech giant Incannex Healthcare Ltd (NASDAQ: IXHL) shared a business presentation of its newly formed psychedelic-assisted therapies subsidiary company, Psychennex Pty Ltd.